Phillip B. Donenberg, Director at Taysha Gene Therapies, Inc. (TSHA), bought 3,000 shares at $7.78 ($23K) on 2022-02-02, disclosed to the SEC on 2022-02-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |